Transferrin targets the highly efficient transcytotic and recycling transferrin receptor (CD71) that is expressed on both nasal and vaginal mucosal epithelium, is actively transcytosed and has been successfully utilized as a delivery system for drug conjugates, when associated with microparticles or emulsion formulations, for the delivery of anti-cancer agents and in gene therapy [17]. This evidence concerns the gene TFRC and cancer.